Health Check
Malaria vaccine backed by WHO
Oct 4, 2023
A new malaria vaccine, developed by the University of Oxford, is recommended by WHO. Women face inequalities in cancer care. Nobel Prize awarded for mRNA vaccine development. The efficacy of mental health first aid courses is debated.
26:29
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The World Health Organization has recommended the use of a cheap vaccine, R21, as a breakthrough in the fight against malaria, with an effectiveness rate of 75%.
- The Lancet Commission on Women, Power, and Cancer highlights the importance of a feminist approach to cancer care, addressing inequalities and improving outcomes for women with cancer.
Deep dives
Malaria Vaccine: A Breakthrough in the Fight Against Malaria
The World Health Organization has recommended the use of a cheap vaccine, R21, as a breakthrough in the fight against malaria. Malaria is caused by a complex parasite, and developing an effective vaccine has been challenging. The R21 vaccine has shown promising results in trials and has now been approved, with an effectiveness rate of 75%. It works by artificially tagging the parasite onto a protein made by the hepatitis B virus, effectively alerting the immune system. This vaccine has the potential to prevent a significant number of malaria cases, particularly in areas where it is widespread.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
